CAPRIE


Also found in: Acronyms, Wikipedia.
Clopidogrel vs. Aspirin in Patients at Risk of Ischemic Events. A trial comparing an antiplatelet agent, clopidogrel, to aspirin in decreasing the risk of stroke, infarction, or vascular death in patients with evidence of vascular disease
Conclusion Long-term clopidogrel is more effective than aspirin in decreasing composite end-points for patients with symptomatic ASHD; clopidogrel’s safety is comparable to medium dose aspirin

CAPRIE

Cardiology A clinical trial–Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events which compared the efficacy of the antiplatelet agent, clopidogrel, with aspirin therapy as a stroke prophylaxis. See Clopidogrel.
References in periodicals archive ?
Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. Clopidogrel versus aspirin in patients at risk of ischemic events.
The purpose of this contract is to carry out geognostic and environmental surveys in the area of the Caprie and Torrazza Piemonte shipyards, Italy, as well as sampling, laboratory testing and report writing.
And while clopidogrel alone resulted in a 24% reduction in vascular events compared with aspirin in patients with PAD in the nearly 20,000-patient Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) trial, the number needed to treat for 1 year to prevent one vascular event was 165.
Tenders Are Invited for Part design of the project management mission of the railway connections of Torrazza and Caprie and the site of deposition of Torrazza.
Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies.
In the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) study and in the Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study, there was an increased risk of bleeding and a decreased benefit with concomitant use of clopidogrel with aspirin compared with aspirin alone in patients aged 75 years and older, according to an FDA spokesperson.
Tenders Are Invited For Executive design of railway fittings of Torrazza and Caprie and of the site of Torrazza Piemonte.
The Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) trial evaluated clopidogrel (75 mg once daily) versus aspirin (325 mg once daily) in reducing the risk of the combined outcome of ischemic stroke, MI, or vascular death in more than 19,000 patients who entered the trial with recent ischemic stroke, recent MI, or symptomatic peripheral vascular disease.